|
Market Cap (5-Jun) $4,960,185 (1,007th) |
Close (30-Jun) $0.038 |
Volume (30-Jun) 1,963,571 |
Shortsold (11-May) 1 (0.00%) (717th) |
|
52w High $0.60 |
52w Low $0.083 |
P/E - |
EPS -0.84 |
CHM released this announcement to the ASX on 15 February 2022, 17:57. The announcement is not marked as price sensitive, and is 2 page(s) in length and 186.65kb in size.
You can view all announcements from CHM and see how they appear on a price chart on the announcements page.
At the date of this announcement, CHM was 0.097% short sold according to ASIC data. It was ranked the 477th most shorted stock on the ASX. It remains ranked 717th as of the latest reported data (11 May 2026).
| Other Recent Announcements from CHM | |
|---|---|
| Notice under section 708A | 29 June 2023, 15:34 |
| Application for quotation of securities - CHM | 29 June 2023, 15:29 |
| Results of Extraordinary General Meeting | 29 June 2023, 11:42 |
| Research Agreement with Penn (supplementary announcement) | 15 February 2022, 17:57 |
| Encouraging data from 2nd dose cohort in CLTX CAR T trial | 8 February 2022, 8:51 |
| Notification regarding unquoted securities - CHM | 7 February 2022, 8:42 |
| Kelly Thornburg appointed Vice President, Head of Quality | 3 February 2022, 10:04 |
You must be logged in to post a reply.
Chimeric Therapeutics Ltd 